Clinical Trial Update: Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether risedronate prevents bone loss in postmenopausal women treated for breast cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Menopause
• Osteopenia

Drugs mentioned

• risedronate (risedronate)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Breast Cancer, Menopause | Phase 3 | Status: COMPLETED